Diversity and plasticity of self recognition during the development of multiple sclerosis

被引:140
作者
Tuohy, VK [1 ]
Yu, M [1 ]
WeinstockGuttman, B [1 ]
Kinkel, RP [1 ]
机构
[1] CLEVELAND CLIN FDN,MELLEN CTR MULTIPLE SCLEROSIS RES & TREATMENT,CLEVELAND,OH 44195
关键词
autoimmunity; demyelination; myelin proteolipid protein; T cell epitopes; encephalomyelitis;
D O I
10.1172/JCI119331
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Recent studies using murine animal model systems indicate that clinical progression of autoimmune disease may be due to the sequential accumulation of neoautoreactivity characterized by extensive plasticity of self recognition. In the present study, we addressed the question of whether a similar paradigm of self recognition is implicated in the development of multiple sclerosis (MS), a demyelinating disease with a presumed autoimmune etiology. Our approach was to determine serial changes over a 12-18-mo period in response to an epitope-mapping series of 265 12-mer peptides of myelin proteolipid protein (PLP) by patients with isolated monosymptomatic demyelinating syndromes (IMDS), a group of distinct clinical disorders with variable Fates of progression to MS. Our data showed that an extensive array of proteolipid protein peptides could elicit autoreactivity. Moreover, differential autoreactive patterns were evident within IMDS patient subpopulations. Monocentric monophasic IMDS patients with no evidence of prior subclinical disease typically showed fully sustained autoreactivity characterized by extensive plasticity, epitope focusing, shifting, and spreading of responses to new self determinants, In contrast, multicentric monophasic IMDS patients with putative evidence of prior asymptomatic lesion formation typically showed partially sustained autoreactivity characterized by abrupt abrogation of responses to an extensive array of self determinants. No sustained autoreactivity was observed in normal control subjects or in patients with other neurologic diseases, Our results indicate that self recognition associated with the development of MS is a developmental process characterized by autoreactive diversity, plasticity, and instability.
引用
收藏
页码:1682 / 1690
页数:9
相关论文
共 50 条
[1]   T-CELLS RESPONSIVE TO MYELIN BASIC-PROTEIN IN PATIENTS WITH MULTIPLE-SCLEROSIS [J].
ALLEGRETTA, M ;
NICKLAS, JA ;
SRIRAM, S ;
ALBERTINI, RJ .
SCIENCE, 1990, 247 (4943) :718-721
[2]   ASSOCIATION OF SUSCEPTIBILITY TO MULTIPLE-SCLEROSIS IN SWEDEN WITH HLA CLASS-II DRB1 AND DQB1 ALLELES [J].
ALLEN, M ;
SANDBERGWOLLHEIM, M ;
SJOGREN, K ;
ERLICH, HA ;
PETTERSON, U ;
GYLLENSTEN, U .
HUMAN IMMUNOLOGY, 1994, 39 (01) :41-48
[3]   PEPTIDES OF MYELIN BASIC-PROTEIN STIMULATE LYMPHOCYTES-T FROM PATIENTS WITH MULTIPLE-SCLEROSIS [J].
BAXEVANIS, CN ;
RECLOS, GJ ;
SERVIS, C ;
ANASTASOPOULOS, E ;
ARSENIS, P ;
KATSIYIANNIS, A ;
MATIKAS, N ;
LAMBRIS, JD ;
PAPAMICHAIL, M .
JOURNAL OF NEUROIMMUNOLOGY, 1989, 22 (01) :23-30
[4]   THE EFFECT OF CORTICOSTEROIDS FOR ACUTE OPTIC NEURITIS ON THE SUBSEQUENT DEVELOPMENT OF MULTIPLE-SCLEROSIS [J].
BECK, RW ;
CLEARY, PA ;
TROBE, JD ;
KAUFMAN, DI ;
KUPERSMITH, MJ ;
PATY, DW ;
BROWN, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (24) :1764-1769
[5]  
BHARDWAJ V, 1994, J IMMUNOL, V152, P3711
[6]   Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein [J].
Brocke, S ;
Gijbels, K ;
Allegretta, M ;
Ferber, I ;
Piercy, C ;
Blankenstein, T ;
Martin, R ;
Utz, U ;
Karin, N ;
Mitchell, D ;
Veromaa, T ;
Waisman, A ;
Gaur, A ;
Conlon, P ;
Ling, N ;
Fairchild, PJ ;
Wraith, DC ;
OGarra, A ;
Fathman, CG ;
Steinman, L .
NATURE, 1996, 379 (6563) :343-346
[7]   FREQUENCY OF T-CELLS SPECIFIC FOR MYELIN BASIC-PROTEIN AND MYELIN PROTEOLIPID PROTEIN IN BLOOD AND CEREBROSPINAL-FLUID IN MULTIPLE-SCLEROSIS [J].
CHOU, YK ;
BOURDETTE, DN ;
OFFNER, H ;
WHITHAM, R ;
WANG, RY ;
HASHIM, GA ;
VANDENBARK, AA .
JOURNAL OF NEUROIMMUNOLOGY, 1992, 38 (1-2) :105-113
[8]   PEPTIDE-SPECIFIC PREVENTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS - NEONATAL TOLERANCE INDUCED TO THE DOMINANT T-CELL DETERMINANT OF MYELIN BASIC-PROTEIN [J].
CLAYTON, JP ;
GAMMON, GM ;
ANDO, DG ;
KONO, DH ;
HOOD, L ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1681-1691
[9]  
CORREALE J, 1995, J IMMUNOL, V154, P2959
[10]   DEVELOPMENT OF REACTIVITY TO NEW MYELIN ANTIGENS DURING CHRONIC RELAPSING AUTOIMMUNE DEMYELINATION [J].
CROSS, AH ;
TUOHY, VK ;
RAINE, CS .
CELLULAR IMMUNOLOGY, 1993, 146 (02) :261-269